SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPY is trending amid concerns over escalating trade tensions between the U.S. and China, with potential tariff implementations looming and some community members fearing a market downturn reminiscent of previous corrections. Discussions include the impact of potential actions from Trump and Powell, and whether current market froth is justified by AI optimism. Some traders are closely watching technical indicators and bracing for volatility ahead of bank earnings and key economic data.

Bitcoin is the first successful internet money based on peer-to-peer technology; whereby no central bank or authority is involved in the transaction and production of the Bitcoin currency. It was created by an anonymous individual/group under the name, Satoshi Nakamoto. The source code is available publicly as an open source project, anybody can look at it and be part of the developmental process.  Bitcoin is changing the way we see money as we speak. The idea was to produce a means of exchange, independent of any central authority, that could be transferred electronically in a secure, verifiable and immutable way. It is a decentralized peer-to-peer internet currency making mobile payment easy, very low transaction fees, protects your identity, and it works anywhere all the time with no central authority and banks.  Bitcoin is designed to have only 21 million BTC ever created, thus making it a deflationary currency. Bitcoin uses the SHA-256 hashing algorithm with an average transaction confirmation time of 10 minutes. Miners today are mining Bitcoin using ASIC chip dedicated to only mining Bitcoin, and the hash rate has shot up to peta hashes.  Being the first successful online cryptography currency, Bitcoin has inspired other alternative currencies such as Litecoin, Peercoin, Primecoin, and so on.  The cryptocurrency then took off with the innovation of the turing-complete smart contract by Ethereum which led to the development of other amazing projects such as EOS, Tron, and even crypto-collectibles such as CryptoKitties.

Bitcoin

Bitcoin is trending amid discussions about market manipulation and potential trade war impacts, with community members debating whether recent price dips represent buying opportunities or signs of a larger correction. Concerns about leveraged positions and insider activity are also circulating, while some analysts maintain a bullish long-term outlook. The digital asset's performance is being closely watched in relation to traditional markets and geopolitical developments.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending due to renewed US-China trade war concerns sparked by China's sanctions on a Korean shipbuilder and the potential for further tariff escalations, creating market volatility. Community discussions revolve around whether these movements are news-driven rather than technical, and whether Trump's actions will reverse the current downturn. Overall sentiment seems mixed, with some expecting a bounce while others anticipate further drawdowns.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst ($BCRX) is trending amid news of its acquisition of Astria Therapeutics ($ATXS) to bolster its HAE portfolio, a move that has sparked mixed reactions. While some investors see long-term growth potential, others express concerns about the acquisition's cost and potential impact on profitability, leading to active discussions about the company's future direction and valuation.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

$CRML is trending as the U.S. aims to secure rare earth elements and reduce reliance on China, sparking community interest in resource independence and potential government support. Discussions revolve around the company's assets in Greenland and the potential for significant growth in a sector deemed critical for national security. Some traders are pointing to a large move in a related ticker, $CLIK, as a reason for caution.

Nova Minerals Ltd. engages in the exploration and development of mineral properties. Its projects include Estelle Gold, RPM, Korbel, Train, Stoney and Studies projects. The company was founded in January 1987 and is headquartered in Melbourne, Australia.

Nova Minerals Limited - ADR

Nova Minerals is trending as discussions revolve around its potential to become a key domestic antimony supplier, especially after the U.S. Department of War awarded funds to Alaska Range Resources (ARR), its subsidiary, to secure the antimony supply chain. The community is focused on the company's unique position with both antimony and gold prospects, viewing it as undervalued compared to other rare earth plays. Some investors express enthusiasm about NVA's long-term growth potential given its Alaskan mining assets.

Greenwave Technology Solutions, Inc. is an emerging growth company, which engages in recycling ferrous metal. It also recycles nonferrous metals including aluminum, copper, stainless steel, nickel, brass, titanium, lead, alloys, and mixed metal products. The company was founded on April 26, 2013 and is headquartered in Chesapeake, VA.

Greenwave Technology Solutions Inc

GWAV is experiencing significant volatility, with community members actively debating its potential for a short squeeze amid filing delays and reverse split speculation. Some traders are capitalizing on the price swings, while others express concerns about the company's financials and management. The stock's low float is also a key point of discussion, contributing to its volatile nature.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

NVTS is trending due to progress in developing GaN and SiC power devices for NVIDIA's next-gen AI factory architecture, specifically supporting the 800 VDC power architecture. The community is focused on the potential for increased efficiency and power density in AI data centers, with some speculating about a possible short squeeze given the stock's high short interest. Some traders are drawing parallels to other AI-related stocks and anticipating further upside.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPMorgan Chase is trending following the release of its Q3 2025 earnings, which revealed profits boosted by investment banking and trading. Community members are actively discussing the better-than-expected revenue and trading results, while also pointing out a net reserve build. Some are speculating on the potential impact of the earnings on the broader market.

PMGC Holdings, Inc. is a physician-dispensed skincare company, which engages in the research and development of skincare formulations. It is involved in the production and commercialization of topical skincare products that contain its proprietary stem cell-derived Elevai Exosomes. The company was founded by Hatem Abou-Sayed, Braeden William Lichti, and Jordan R. Plews on June 9, 2020 and is headquartered in Newport Beach, CA.

PMGC Holdings Inc

PMGC Holdings Inc.

ELAB is trending due to a premarket surge, fueled by retail trader interest in PMGC Holdings' shift towards biotech and industrial sectors. Community discussions revolve around the stock's low float and potential for a squeeze, while some traders are pointing to possible overextension. The stock's volatility and previous reverse splits are also being discussed.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Mizuho Securities raised price targets on several large U.S. health insurers following the release of the latest Medicare Advantage star ratings, noting improved visibility into earnings.Analyst Ann Hynes raised her target on CVS Health to $88 from $76, UnitedHealth to $430 from $300, Elevance Health to $420 from $342 and Humana to $345 from $300 and maintained an 'Outperform' rating on all four stocks. The firm also lifted Centene’s target to $40 from $28 with a 'Neutral' rating.Hynes said the target changes were driven by a broader rotation into the healthcare sector after the U.S. government released its 2026 quality ratings for Medicare Advantage and prescription drug plans, which help determine bonus payments to insurers.Barclays also raised its price targets in the group, lifting UnitedHealth’s to $386 from $352 and Elevance Health’s to $395 from $373, both with Overweight ratings. The firm said Medicare remains the most stable business line, Medicaid the most uncertain, and Affordable Care Act exchanges are improving both “fundamentally and from a policy perspective.”CVS Health’s Aetna unit led with over 81% of members in top-rated programs, followed by UnitedHealth at 78%, Elevance at 55%, and Humana at 20%, according to federal data and company disclosures.In all, 64% of Medicare Advantage members with drug coverage are signed up for plans that get four or five stars, Oppenheimer said. The Centers for Medicare &amp; Medicaid Services rates plans on metrics including patient satisfaction, and performance on cancer screenings and management of chronic conditions, among others, according to a Reuters&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/legal/litigation/cvs-says-over-81-members-are-high-rated-medicare-advantage-plans-2026-2025-10-09/">report</a>.Four and five-star plans receive bigger government payments that could add up to billions of dollars and have a financial impact in 2027, Oppenheimer said. The research firm added that results broadly matched expectations following company pre-announcements.&nbsp;Elevance showed one of the largest year-over-year gains, with 55% of its membership now in plans rated four stars or higher, up from 40% a year ago, while CVS said 63% of Aetna members are in 4.5-star plans. UnitedHealth said 40% of its members are in 4.5-star plans, and Humana reported 1.2 million members in highly rated offerings.Centene’s Wellcare CEO Michael Carson said the company was encouraged by progress in its star ratings.On Stocktwits, retail sentiment was ‘bullish’ for CVS Health amid ‘normal’ message volume, while sentiment for UnitedHealth, Elevance Health, Humana, and Centene was ‘bearish’ with ‘low’ message volume.So far this year, CVS Health shares are up 77%, while Humana has gained 16%. In contrast, UnitedHealth is down 26%, Elevance Health has slipped 2%, and Centene has dropped 38%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the United States Medicare logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

CVS, UnitedHealth, Elevance, Humana Gain Price Target Hikes On Wall Street After Medicare Star Ratings Update

Barclays raised targets on UnitedHealth and Elevance, saying Medicare remains the most stable business line, Medicaid the most uncertain, and Affordable Care Act exchanges are improving both fundamentally and from a policy standpoint.

Equity

Can Digital Workflows at Optum Rx Transform UNH's Patient Experience?

UnitedHealth drives a digital overhaul at Optum Rx, automating pharmacy workflows to boost efficiency and enrich patient care.

UnitedHealth Jumps 12% in a Month: But is it Healthy Enough to Buy?

UNH surges 12% in a month, but with rising costs and regulatory pressures, is now the time to buy or wait?

Humana Benefits From Rising Premiums Amid High Benefit Ratio

HUM gains from rising premiums, Medicare growth and CenterWell expansion, but faces pressure from high benefit ratios and costs.

Cigna to Support Cleerly's AI Cardiovascular Imaging Solutions

CI expands coverage to Cleerly's AI cardiovascular imaging, boosting access, early detection and digital healthcare adoption.

Centene Sits at 13.25X P/E: Time to Load Up or Look Away for Now?

CNC's low 13.25X P/E may look attractive, but falling margins, heavy debt and shrinking memberships paint a tougher picture.

CVS Health Steps Up to Bolster Oak Street as Cost Pressures Mount

CVS trims its outlook as Oak Street faces rising medical costs, but new leadership and tech upgrades aim for steady growth.

Arista Networks and Elevance Health have been highlighted as Zacks Bull and Bear of the Day

Arista Networks shines with soaring sales and earnings beats, while Elevance Health cuts guidance and struggles in 2025.

Bear of the Day: Elevance Health (ELV)

Lowered guidance has been a driving force behind the poor share performance, with EPS revisions remaining bearish. 

New Strong Sell Stocks for September 15th

CE, ELV and ARR have been added to the Zacks Rank #5 (Strong Sell) List on September 15, 2025.

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Health Benefits, CarelonRx, Carelon Services, and Corporate and Other. The Health Benefits segment offers a comprehensive suite of health plans and services to different customers. The CarelonRx segment markets and offers pharmacy services to affiliated health plan customers, as well as to external customers. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services with the aim of delivering whole health affordably by offering a broad array of healthcare related services. The Corporate & Other segment includes businesses that do not individually meet the quantitative threshold for an operating segment. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Elevance Health Inc

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

Current Price	$351.42
Prev Close	$353.24
Open	$351.15
Dividend Yield	1.77%
50-Day Moving Average	$315.75
Beta	0.31
Avg. Volume	2.01M
PE Ratio	14.96

52-Week High	$497.34
52-Week Low	$273.71
Market Capitalization	$79.13B
EPS (Annual)	$25.68
Price to Book	1.81
Revenue Per Employee	$1.7M
Enterprise Value/EBITDA	N/A

ELV
Elevance Health Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ELV News

ELVElevance Health Inc